CRDL logo

CRDL Cardiol Therapeutics Inc.

NASDAQ Capital Market · Drug Manufacturers - Specialty & Generic · Healthcare

$1.00
-0.01 (-0.99%)

Cardiol Therapeutics Inc. is a clinical-stage life sciences firm dedicated to discovering and advancing anti-fibrotic and anti-inflammatory therapies for cardiovascular disease (CVD). Its leading candidate, CardiolRx, is currently undergoing a multi-national, randomized, double-blind, placebo-controlled Phase II/III study. Furthermore, the company is developing a subcutaneous version of CardiolRx,…

Market Cap: $120.66Mwww.cardiolrx.com

Price

No data yet.

Social Signal Score

30
5d
—
30d
30
1 mentions
—
60d
30
1 mentions
—
90d
31
4 mentions
—
news: 4

Analyst Ratings

2 analysts
Buyconsensus
Strong Buy 0Buy 2Hold 0Sell 0Strong Sell 0
Avg price target$8+700.0%
Low $8Median $8High $8
Current Consensus

Revenue

$0.00
$0.00$26.3K$52.5K$78.8K
Jun 2017Jun 2026

Analyst Estimates

FY2025
$-0.46
$-0.53–$-0.40
2 analysts
FY2026
$-0.45
$-0.56–$-0.30
3 analysts
FY2027
$-0.32
$-0.39–$-0.14
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
David G. Elsley
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
18
Beta
0.52
Country
CA
Piotroski score
2 / 9 (Weak)
Altman Z-score
5.42
www.cardiolrx.com